| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Tiziana Life Sciences Ltd's insiders have accumulated 321,423 shares worth roughly $319K on balance. In the past 30 days, 1 insider bought and 0 sold. Purchases have clustered in the most recent filings.
Leading the buying is Elrifi Ivor (Chief Executive Officer), now holding an estimated $4.8M in TLSA. Purchases at the executive level are worth more attention than sales, since sales can be prompted by tax or liquidity needs rather than a view on the stock.
TLSA sits in the Biotechnology industry within the Healthcare sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 44.77M | $45.22M | - | |
| CEO | 4.79M | $4.84M | +321.4K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | Elrifi Ivor | Chief Executive Officer | Buy | 321,423 | $0.99 | $318,908.79 | +3.6% |